Market Survey Aimed At The Subsequent Direct Award Of The Supply Of Reagents And Consumables For The Quantitative Determination Of The Transcripts Mbrc::Abl (P210); Mbcr::Abl (P190), Pml::Rara (Bcr1, Bcr2 And Bcr3 Variants) And Cbfbmyh11 For The Monitoring Of Minimal Residual Disease In Patients Affected By Chronic Myeloid Leukemia (Cml), Philadelphia B-Cell Lymphoblastic Leukemia Positive (Phalph+) And Acute Myeloid Leukemia (M3 And Inv16) For The Needs Of The Genetic And Genomic Diagnostic Uosd Of The Ulss 8 Berica Company.

AZIENDA ULSS N. 8 BERICA Italy has Released a tender for Market Survey Aimed At The Subsequent Direct Award Of The Supply Of Reagents And Consumables For The Quantitative Determination Of The Transcripts Mbrc::Abl (P210); Mbcr::Abl (P190), Pml::Rara (Bcr1, Bcr2 And Bcr3 Variants) And Cbfbmyh11 For The Monitoring Of Minimal Residual Disease In Patients Affected By Chronic Myeloid Leukemia (Cml), Philadelphia B-Cell Lymphoblastic Leukemia Positive (Phalph+) And Acute Myeloid Leukemia (M3 And Inv16) For The Needs Of The Genetic And Genomic Diagnostic Uosd Of The Ulss 8 Berica Company. in Healthcare and Medicine. The tender was released on Oct 11, 2024.

Country - Italy

Summary - Market Survey Aimed At The Subsequent Direct Award Of The Supply Of Reagents And Consumables For The Quantitative Determination Of The Transcripts Mbrc::Abl (P210); Mbcr::Abl (P190), Pml::Rara (Bcr1, Bcr2 And Bcr3 Variants) And Cbfbmyh11 For The Monitoring Of Minimal Residual Disease In Patients Affected By Chronic Myeloid Leukemia (Cml), Philadelphia B-Cell Lymphoblastic Leukemia Positive (Phalph+) And Acute Myeloid Leukemia (M3 And Inv16) For The Needs Of The Genetic And Genomic Diagnostic Uosd Of The Ulss 8 Berica Company.

Deadline - Nov 04, 2024

GT reference number - 95300005

Product classification - Medical equipments, pharmaceuticals and personal care products